Zobrazeno 1 - 10
of 14
pro vyhledávání: '"G S, Limouris"'
Autor:
S. K. Shukla, Klemens Scheidhauer, G. S. Limouris, W.-G. Franke, B. Hientzsch, H. Schicha, K. Schomäcker, T. Fischer, A. Scharl, K. Jantsch
Publikováno v:
Nuklearmedizin. 34:32-39
ZusammenfassungEs wurden die Unterschiede der Yttrium-Biokinetik an männlichen, tumortragenden Mäusen bei Variationen der Applikationsart (intraperitoneal bzw. intratumoral) und des Tumortyps (Mammakarzinom, Melanom) nach Applikation von 87Y-Zitrat
Publikováno v:
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.... 55(1)
In this study, a new method has been used to predict pain response to (186)Re-HEDP therapy in patients suffering from painful osseous metastases, on the basis of a modified bone scan index and pre-therapy pain scoring.Forty five patients received a t
Autor:
S K, Shukla, G S, Limouris, R, Cusumano, A, Acconcia, C, Cipriani, G, Atzei, G, Argirò, S, Boemi
Publikováno v:
Anticancer research. 17(3B)
Androgen deprivation therapy remains so far the mainstay of advanced prostate cancer treatment. Although it improves the quality of life of the patient for some time, the disease progresses and soon it becomes hormonally unresponsive. The object of o
Autor:
S K, Shukla, G S, Limouris, R, Cusumano, A, Acconcia, C, Cipriani, G, Argiro, G, Atzei, S, Boemi
Publikováno v:
Anticancer research. 17(3B)
There have been no major advances in the systemic detection of renal cell carcinoma (RCC) and its unpredictable metastases. Surgery, thus, remains the mainstay of the curative treatment for the localized disease. The propose of the present study has
Autor:
G S, Limouris, S K, Shukla, A, Condi-Paphiti, C, Gennatas, I, Kouvaris, N, Vitoratos, A, Manetou, C, Dardoufas, V, Rigas, L, Vlahos
Publikováno v:
Anticancer research. 17(3B)
The efficacy and toxicity of treatment with 1400 +/- 100 MBq of Re-186-HEDP were evaluated in women with osseous metastatic breast cancer. The follow-up period was fourteen weeks. The efficacy of treatment was assessed by a) a pain and performance qu
Publikováno v:
Anticancer research. 17(3B)
Although bone scintigraphy using Tc-99m labelled diphosphonates is a highly sensitive modality for the detection of of the extent of secondary skeletal malignancies, it is often not sufficient since possible bone marrow participation cannot be imaged
Autor:
A, Manetou, G S, Limouris
Publikováno v:
Anticancer research. 17(3B)
Thallium-201 with a half-life of 73 hours, decays by electron capture and as a consequence emits numerous Auger electrons. When it localises in the cell nucleus it causes enhanced biological effects. Technetium-99m with a half-life of 6 hours, radiat
Autor:
G S, Limouris, S K, Skukla
Publikováno v:
Anticancer research. 17(3B)
In bone scintigraphy extraosseous uptake of the radiopharmaceutical (TcO4-, pertechnetate) is a common finding when the stomach is abnormally observed; this may be due to the instability of the radiopharmaceutical leading to free pertechnetate within
Publikováno v:
Anticancer research. 17(3B)
The purpose of lymphoscintigraphy in patients with melanoma before surgery is to image the lymphatic drainage net and particularly to detect the sentinel node; the purpose of immunolymphoscintigraphy after surgery is to map the lymphatic drainage and
Publikováno v:
Radioactive Isotopes in Clinical Medicine and Research ISBN: 9783034877749
Sr-89 Chloride1,2,6,9 and Re-186-HEDP 3,4,6 have been proposed as two very promising radiopharmaceuticals for the palliative treatment of bone metastatic pain. Besides the worldwide efforts to achieve optimal doses for longest possible analgetic dura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68364f4c2471c63016de62670d06d81f
https://doi.org/10.1007/978-3-0348-7772-5_56
https://doi.org/10.1007/978-3-0348-7772-5_56